Spain · Delayed Price · Currency is EUR CLERHP Estructuras Statistics
Total Valuation
BME:CLR has a market cap or net worth of EUR 400.40 million. The enterprise value is 416.18 million.
| Market Cap | 400.40M |
| Enterprise Value | 416.18M |
Important Dates
The last earnings date was Wednesday, May 13, 2026.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BME:CLR has 18.04 million shares outstanding. The number of shares has increased by 24.15% in one year.
| Current Share Class | 18.04M |
| Shares Outstanding | 18.04M |
| Shares Change (YoY) | +24.15% |
| Shares Change (QoQ) | +49.95% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 0.74% |
| Float | 10.08M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 130.59 |
| PS Ratio | 28.30 |
| PB Ratio | 25.19 |
| P/TBV Ratio | 25.47 |
| P/FCF Ratio | 1,774.26 |
| P/OCF Ratio | 416.60 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 59.85, with an EV/FCF ratio of 1,844.17.
| EV / Earnings | n/a |
| EV / Sales | 29.42 |
| EV / EBITDA | 59.85 |
| EV / EBIT | 70.00 |
| EV / FCF | 1,844.17 |
Financial Position
The company has a current ratio of 1.24, with a Debt / Equity ratio of 1.49.
| Current Ratio | 1.24 |
| Quick Ratio | 0.30 |
| Debt / Equity | 1.49 |
| Debt / EBITDA | 3.41 |
| Debt / FCF | 105.06 |
| Interest Coverage | 2.03 |
Financial Efficiency
Return on equity (ROE) is -7.41% and return on invested capital (ROIC) is -1,907.47%.
| Return on Equity (ROE) | -7.41% |
| Return on Assets (ROA) | 4.45% |
| Return on Invested Capital (ROIC) | -1,907.47% |
| Return on Capital Employed (ROCE) | 24.49% |
| Weighted Average Cost of Capital (WACC) | -60.08% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 100 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BME:CLR has paid 975,598 in taxes.
| Income Tax | 975,598 |
| Effective Tax Rate | 10,226.39% |
Stock Price Statistics
The stock price has increased by +374.03% in the last 52 weeks. The beta is 1.14, so BME:CLR's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +374.03% |
| 50-Day Moving Average | 18.12 |
| 200-Day Moving Average | 9.69 |
| Relative Strength Index (RSI) | 58.39 |
| Average Volume (20 Days) | 18,501 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BME:CLR had revenue of EUR 14.15 million and -971,806 in losses. Loss per share was -0.05.
| Revenue | 14.15M |
| Gross Profit | 15.06M |
| Operating Income | 5.95M |
| Pretax Income | 9,540 |
| Net Income | -971,806 |
| EBITDA | 6.95M |
| EBIT | 5.95M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 8.04 million in cash and 23.71 million in debt, with a net cash position of -15.67 million or -0.87 per share.
| Cash & Cash Equivalents | 8.04M |
| Total Debt | 23.71M |
| Net Cash | -15.67M |
| Net Cash Per Share | -0.87 |
| Equity (Book Value) | 15.89M |
| Book Value Per Share | 0.88 |
| Working Capital | 17.59M |
Cash Flow
In the last 12 months, operating cash flow was 961,128 and capital expenditures -735,456, giving a free cash flow of 225,672.
| Operating Cash Flow | 961,128 |
| Capital Expenditures | -735,456 |
| Depreciation & Amortization | 1.01M |
| Net Borrowing | 5.70M |
| Free Cash Flow | 225,672 |
| FCF Per Share | 0.01 |
Margins
Gross margin is 106.46%, with operating and profit margins of 42.03% and -6.87%.
| Gross Margin | 106.46% |
| Operating Margin | 42.03% |
| Pretax Margin | 0.07% |
| Profit Margin | -6.87% |
| EBITDA Margin | 49.16% |
| EBIT Margin | 42.03% |
| FCF Margin | 1.60% |
Dividends & Yields
BME:CLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -24.15% |
| Shareholder Yield | -24.15% |
| Earnings Yield | -0.24% |
| FCF Yield | 0.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for BME:CLR is 21.15, which is -4.73% lower than the current price. The consensus rating is "Strong Buy".
| Price Target | 21.15 |
| Price Target Difference | -4.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 194.66% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BME:CLR has an Altman Z-Score of 0.95 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.95 |
| Piotroski F-Score | 5 |